Aplasia medular asociada al uso de ticlopidina: Report of one case
2002; Q16635223; Volume: 130; Issue: 7 Linguagem: Inglês
10.4067/s0034-98872002000700013
ISSN0717-6163
AutoresCarolina Ruiz B, Tatiana Monroy A, Nelson Montaña N, Pilar Lora L, Rubén Lamich B, Alejandro Valderrama R,
Tópico(s)Pneumocystis jirovecii pneumonia detection and treatment
ResumoWe report a 58 years old male that developed a bone marrow aplasia associated to the use of ticlopidine, prescribed after coronary artery stenting. The patient developed a pneumonia as a complication. He was admitted to the Intermediate Treatment Unit, receiving wide spectrum antimicrobial therapy and a granulocyte colony stimulating factor (Neupogen(r)) with favourable response. Ticlodipine is an effective antiplatelet agent, but has serious hematological and other side effects. Its prescription requires a close follow up and search for complications.
Referência(s)